A selective and potent inhibitor of neuraminidases, a hydrolase that is responsible for processing sialylated glycoconjugates, is a promising drug candidate for various infective diseases. The current study demonstrates that the use of an aglycone-focused library of 2-difluoromethylphenyl -sialosides is an effective technique to find potent and selective mechanism-based labeling reagents for neuraminidases. The focused library was constructed from a 4-azide-2-difluoromethylphenyl sialoside (2) and an alkyne-terminated compound library by a click reaction. The focused library showed different inhibition patterns for two neuraminidases, Vibrio cholerae neuraminidase (VCNA) and human neuraminidase 2 (hNeu2), and the most potent inhibitors for each neuraminidase were selected. A kinetic analysis of the selected inhibitors demonstrated that the modification of the aglycone moiety improved the K I value with little change in the t 1/2 value of the enzyme activity relative to the basic skeleton (2).
Introduction
Neuraminidases (NAs; EC 3.2.1.18), an important family of glycoside hydrolases, cleave the glycosidic linkages of sialic acid (Neu5Ac; N-acetylneuraminic acid) and regulate the interactions between a cell and the extracellular world during infection, development, inflammation, antigenicity, and cell-cell adhesion. 1 Thus, inhibition of neuraminidases is a potential target for therapeutic reagents. Since the first report in 1969, 2,3-dehydroneuraminic acid (DANA; Figure 1 neuraminidases might be due to the flexibility of the cavities around the active sites of neuraminidases. 5, 6 The cavities of neuraminidases are primarily composed of a loop moiety on a six-bladed β-propeller fold, and despite their low sequence identities, this structural feature is preserved among every species among eukaryote, prokaryote, and virus. 7, 8 The flexibility of the loop structure makes it difficult to design an inhibitor by a structure-based drug-design strategy using only the static information available from crystal structures. Previously, we reported a strategy to develop a potential inhibitor ( Figure 1 ) for Vibrio cholerae neuraminidase (VCNA) using labeling information that was obtained from a dansyl-modified 2-difluoromethylphenyl-type sialoside, 1a
( Figure 2a) . 9 ,10 A focused library was prepared from 9-N 3 -substituted DANA, and an alkyne-terminated compound library was designed based on the labeling information. A tailored inhibitor for VCNA that is selective and potent (K I = 73 nM) was successfully identified. The use of a focused library to probe a suitable structure for the inhibition of the hydrolytic function of neuraminidases is a potential method of finding a potent and selective inhibitor for each neuraminidase. 9 2-Difluoromethylphenyl-type sialosides, which are mechanism-based inactivators for neuraminidases such as the probe 1a, also provide an attractive alternative to the DANA-based competitive inhibitors. The 2-difluoromethyl-type sialoside is activated by the hydrolytic cleavage of a phenolic glycoside bond. Following fluoride ion desorption, the activated sialoside forms a Michael reaction acceptor, which forms a covalent bond with nucleophiles, and the activated acceptor moiety binds to nucleophilic amino acid side chains to inhibit the enzymatic activity ( Figure 2b ). The function-specific activation by a neuraminidase (sialidase) and the irreversible labeling ability of the 2-difluoromethylphenyl sialoside have potential as novel drug and diagnostic tools. This 2-difluoromethylphenyl-type glycoside was first reported in 1990 by Danzin et al. as a glucosidase inhibitor, 11 and it has been applied to various glycosidases, such as galactosidases,
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N-acetyl glucosaminidase 13 ; other hydrolases, such as phosphatases, 14 sulfatase, 15 and proteases 16 ; and neuraminidases. 10, [17] [18] [19] Recently, we reported that another 2-difluoromethylphenyl-type sialoside (1b) (Figure 2a ) inhibits the sialidase activity of a Trypanosoma cruzi trans-sialidase (TcTS) and that a host cell infection by T. cruzi is also inhibited by treatment with compound 1b. 20 A point mutation of an amino acid residue that is detected by the labeling study with 1a almost completely abolishes the activity of TcTS. Although there are advantages to the 2-difluoromethylphenyl-type sialoside, a relatively high concentration (mM range) of this glycoside is required to inhibit the target enzymes. This problem may be due to the basic architecture of this type of compound; only a glycan moiety can assume the potency and specificity of this type of glycoside to be recognized by target enzymes. To overcome this problem, we sought to design a focused library consisting of the 2-difluoromethylphenyl sialoside skeleton (2) to which we could add the aglycone moiety with potent and specific affinity to each target neuraminidase by the so- (Figures 2b, 2c) . 22, 23 Previous research has indicated that the activation rate of the aglycone moiety (k 2 ) is slower than its dissociation rate from an active site on the target enzyme (k 4 ). 15, 19 The aglycone-focused library, 3, prepared from 2 might also improve this problem. Neuraminidases must have sufficient space in the active site to recognize large glycoconjugates, such as glycoproteins and glycolipids, and the structurally randomized aglycone moiety of the mechanism-based inhibitor 2. We now report the preparation of both compound 2 and the focused library 3 and the evaluation of 3 regarding the inhibition potency and selectivity for VCNA and human neuraminidase 2 (hNeu2).
Results and Discussion

Preparation and biochemical evaluation of 4-azide-2-difluoromethylphenyl sialoside 2
The azide-equipped aglycone moiety (6) was prepared from 5-nitrosalicylaldehyde (4) as shown in Scheme 1. The direct reduction of the nitro group of 4 yielded a complex mixture due to the instability of the amine and intermolecular imine formation. To avoid this instability, the carbonyl group of 4 was converted to a dithioacetal to yield 5. The nitro group of 5 was then converted to an azide group by treatment with zinc, sodium nitrite, and sodium azide to yield 6. 24 The deprotection of the dithioacetal group 25 at the 2-position and the formation of a diazonium salt at the 4-position were simultaneously accomplished by treatment with 4 equivalents of sodium nitrite.
The azide-equipped skeleton of the suicide substrate 2 was prepared by an established procedure 10, 11, 17 as shown in Scheme 2. The methyl ester of sialic acid 8 was coupled with 6 in a one-pot reaction 26 via a glycosyl chloride intermediate to yield the α-sialoside 9. The aldehyde group of 9 was converted to a difluoromethyl group by treatment with diethylamino sulfer trifluoride (DAST) to yield 10. The two-step deprotection of 10, i.e., the sodium methoxide-catalyzed O-acyl Scheme 1. Preparation of 5-azidesalicylaldehyde (6). Reagents and conditions: (i) 1,3-propanedithiol (1.2 eq), BF3·Et2O (1.2 eq), CH2Cl2, r.t., 30 min, 95%, (ii) a: Zn (5.0 eq), AcOH, r.t., 1 h, b: NaNO2 (4.0 eq), AcOH, 0 °C, 2 h, c: NaN3, AcOH, 0 °C→r.t., 30 min, 65% (in 3 steps).
replacement in methanol followed by the saponification of the methyl neuraminate, yielded the basic skeleton 2.
The kinetic constants of the time-dependent inhibition (K I , k inact , and t 1/2 ) of VCNA and hNeu2 by 2 were explored according to a method of an irreversible inhibitor reported by Kitz and Wilson. 11, 22, 23 Each enzyme was preincubated with 2, and an aliquot of the solution was added to a solution of 2--(4-methylumbelliferyl)-N-acetylneuraminic acid (4-MU-NANA) to determine the residual activity in 5-min intervals. As shown in Table 1 
First screening of the focused library 3 prepared by the click reaction
For the first screening, we adapted a direct analysis of the crude solution of the click reaction as previously reported. 9 The azide-equipped skeleton 2 was coupled with a commercially available sulfoxide (DMSO) to afford the aglycone randomized suicide substrate library 3. Before the first screening, the effect of the reagents of the click reaction on the hNeu2 activity was evaluated. In the case of VCNA, 9 its NA activity was only slightly affected by the reagents. Itzstein et al. reported that hNeu2 require calcium ion for their NA activity, and the NA activity decreases by one-half by the addition of 7 mM copper salt. 28 As shown in Figure 3a , the NA activity of hNeu2 disappeared in the presence of a copper salt even at a very low copper concentration (50 μM CuSO 4 ) in the presence of 4 mM calcium salt. To negate the effect of the copper salt, the effect of a chelating agent for the copper ion, 2-({2-[bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino) acetic acid (EDTA) was evaluated. Although Itzstein et al. reported that 1 mM EDTA also decreased the NA activity of hNeu2 by half, 28 addition of 1 equivalent of EDTA recovered the NA activity of hNeu2 completely, and a small excess of EDTA did not affect the activity ( Figure 3 ). The reported inhibition effect in the presence of 1 mM EDTA might be due to the absence of external addition of calcium ion. 28 Based on these results, 2.5 equivalents of EDTA were added to the assay solution to bind the copper ion for the first screening of hNeu2.
The yield of the click reaction in each crude solution was roughly estimated from the ratio of 2 and 3 obtained from the product ion signal of the ESI-MS analysis. 9, 29 For 90 of the compounds, no product was determined from the ESI-MS analysis, whereas for 45 of the compounds, the yields of the product were less than 50%. Among these compounds, those possessing a thiourea group and an imine group tended to produce low yields, and this tendency differs from the results obtained using an aliphatic azide. 9 A yield of greater than 70% was obtained for 78 reaction solutions in the ESI-MS analysis, and these compounds were used for the first screening with VCNA and hNeu2 ( Figure min and diluted with 2 mM of 4-MU-NANA, and the remaining NA activity was analyzed using a fluorometric assay method. 30 A 125-μM solution of EDTA was also added to the preincubation solution of hNeu2, which also contained 50 μM CuSO 4 .
As shown in Figure 4b , the different inhibition patterns of focused library 3 for VCNA and hNeu2
clearly demonstrated the potency of our strategy to give the mechanism-based labeling reagent selectivity and inhibition potency for each of the neuraminidase. 
Determination and evaluation of the best structure of 3 as an inhibitor of VCNA and hNeu2
To determine the best structure from the focused library 3 to inhibit VCNA, the results in Figure   4b were classified into two groups using 55% of the remaining NA activity as the borderline of the first screening. The compounds that exhibited less than 55% remaining NA activity were prepared as purified compounds. Among the compounds that passed the first screening, the 11 candidates from the focused library 3 shown in Figure 5a could be isolated and used for the second screening. A comparison of the kinetic constants of compounds 2 and 3a for VCNA and compounds 2 and 3b for hNeu2 indicated that the K I value changed by approximately one-hundredth owing to the modifications in both cases. These differences in binding properties between the basic skeleton and the hit compounds are larger than that of the DANA-based inhibitor, which was reported previously to be approximately one-tenth. 9 This result indicates that the modification of the aglycone moiety via the triazole linker greatly contributed to make sialoside 3 a good substrate to bind to the active site of the target enzyme, as we expected. In contrast to the K I values, the change in t 1/2 for both neuraminidases was slightly increased. This result indicates that the modification of the aglycone moiety did not contribute to the change of the rate of hydrolysis (k 1 , Figure 2c ), the activation rate of the released aglycone (k 2 ), or the covalent bond formation that inactivated the enzyme (k 3 ). Rather, the substituent on the difluoromethylphenyl moiety is thought to decrease the k 1 value by inhibiting the ability of the enzyme to hydrolyze the substrate, as we observed for our DANA-based inhibitors. 9 Replacement of the azide functional group on the difluoromethylphenyl group with 1,2,3-triazol might also affect the kinetics (k 1-3 ) based on the electrostatic change at the phenolate moiety. An aglycone-focused library of 2-difluoromethylphenyl sialoside (3) was efficiently constructed from the azide-equipped skeleton 2 and an alkyne-terminated compound library using the click strategy. Two new lead structures, 3a and 3b, were determined to be potent and selective inhibitors for VCNA and hNeu2, respectively, by a two-step screening, i.e., the crude click reaction mixture was used for the first screening, and the isolated compounds were used for the second screening.
Although hNeu2 was found to be deactivated almost completely by copper ions (M concentration range) during the click reaction of the first screening, nullification of this effect was achieved by the addition of a small excess of EDTA. Although it tended to decrease the rate of inactivation, the substituent on the aglycone moiety greatly contributed to the binding properties of the sialoside 3 in terms of both potency and selectivity.
Further studies to elucidate the customized lead structure for other targets, such as the influenza virus neuraminidase and Trypanosoma cruzi trans-sialidase, are now in progress.
Experimental
General
2--(4-methylumbelliferyl)-N-acetylneuraminic acid (4-MU-NANA) was synthesized according
to published methods. 31 The alkyne compounds were purchased from Thermo Fisher Scientific Inc. 
2-(1,3 -d ith ian-2-y l) -4-nitropheno l ( 5)
BF 3 ·Et 2 O (12.1 mL, 48 mmol) was gradually added to a solution of 2-hydroxy-5-nitrobenzaldehyde (4) (6.7 g, 40 mmol) and propane-1,3-dithiol (4.88 mL, 48 mmol) in dry CH 2 Cl 2 (200 mL), and the mixture was stirred under a N 2 gas atmosphere at room temperature.
After 2 h, the reaction was quenched by MeOH, and the solvent was removed under reduced pressure followed by recrystallization from ethyl acetate-hexane to yield a light yellow powder (9.78 g, 95% 
5-azido-2 -hyd roxyben zaldehyde (6 )
Zn powder (5.6 g, 86 mmol) was added to a solution of 2-(1,3-dithian-2-yl)-4-nitrophenol (5) (4.4 g, 17 mmol) in AcOH (100 mL), and the mixture was stirred at room temperature for 1 h. The residue was filtered through a celite pad, and the pad was washed with EtOAc. The combined solutions were removed under reduced pressure. The residue was dissolved in glacial acetic acid (100 mL) and cooled on an ice bath to < 5 °C. While stirring, a solution of sodium nitrate (1.72 g, 69 mmol) dissolved in a minimum amount of water was added dropwise, and mixing was continued for 2 h. Sodium azide (1.70 g, 26 mmol) was dissolved in a minimal amount of water and added dropwise to the mixture. After 30 min, the glacial acetic acid was roughly removed under reduced pressure. The residue was extracted with EtOAc, and the organic phases were washed with sat. 
Methy l [ 4-a zido -2-formylphenyl
5-acetamido-4,7,8,9-tetra-O-ace tyl-3 ,5-d ideox y-D -glycero --D -ga lac to-non-2-ul opyranoside ]ona te ( 9 )
A suspension of methyl 5-acetamido-3,5-dideoxy-D-glycero--D-galacto-non-2-ulopyranosonate (8) (969 mg, 3.0 mmol) in acetyl chloride (10 mL) was vigorously stirred under a N 2 gas atmosphere at room temperature for 36 h. The resulting solution was concentrated and co-evaporated with toluene three times. Diisopropylethylamine (1.57 mL, 9.0 mmol) was added dropwise to a suspension of the residue and 5-azido-2-hydroxybenzaldehyde (6) (490 mg, 3.0 mmol) in acetonitrile (30 mL), and the mixture was stirred under a N 2 gas atmosphere at room temperature for 24 h. After the solvent was evaporated in vacuo, the residue was purified by flash column chromatography on a silica gel (hexane:acetone = 7:4) to yield compound 9 as a yellow powder (1.16 g, 61%). 
2-diflu oromethy l -4-a zidophenyl
5-acetoamido -3,5-d ide oxy-D -g lycero--D-ga lacto-n on-2 -ulop yrano s idonic acid (2)
A solution of 5 M sodium methoxide in MeOH (450 L) was added dropwise to a solution of 10 (620 mg, 0.94 mmol) in MeOH (10 mL), and the reaction mixture was stirred under a N 2 gas atmosphere at room temperature for 2 h. To neutralize the excess sodium methoxide, 1% acetic acid was added, and the mixture was concentrated in vacuo. The residue was dissolved in H 2 O (8.5 mL), and 1 N NaOH (1.5 mL) was added dropwise to the mixture, which was then stirred at room temperature for 1 h. 
Construction of the libraries 3 for first screening
Aqueous solutions of compound 2 (100 mM), sodium ascorbate (66.7 mM), and CuSO 4 (100 mM) and dimethylsulfoxide solutions of TBTA (100 mM) and the alkyne compounds (100 mM)
were prepared. Each alkyne compound (5 L) was added to CuSO 4 (2.5 L), TBTA (2.5 L), compound 2 (5 L), and sodium ascorbate (35 L), and the mixture was incubated for 8 h. The yields of the triazole compounds were roughly estimated by comparison between the ESI-MS signal intensity of compound 2 and that of each triazole product 3. The solutions with a greater than 70%
yield of the triazole product 3 were used for the following screening assay.
General procedure for preparation of click compound 3
Solutions of compound 2 (100 mM), sodium ascorbate (250 mM), and CuSO 4 (100 mM) in H White solid (64% For the VCNA residual activity assay, the VCNA activity was measured in 100 mM MES buffer (pH 6.5) containing 4 mM CaCl 2 and 2 mM 4-MU-NANA at 25 °C. The enzyme reaction was initiated by the addition of the pre-incubated enzyme solution in a final volume of 60 L. The VCNA activity was estimated by monitoring the increase in the fluorescence due to the hydrolysis of 4-MU-NANA using an excitation wavelength of 365 nm and an emission wavelength of 450 nm.
The residual activity was estimated by comparison with the control, which was obtained in the absence of the inhibitor.
First and second scree ning (Human neuraminidase 2; hNeu2 )
For the Neu2 pre-incubation experiment, Neu2 (10.6 mU), inhibitor3 (final concentration 100 M 
Determina tion of K I an d k i n a c t and t 1 / 2 va lues (hNeu2)
For the hNeu2 pre-incubation experiment, hNeu2 (10.6 mU), several concentrations of inhibitor 3
(50-500 M), and BSA (20 g) were pre-incubated in 33 mM MES buffer (pH 6.5) with 4 mM CaCl 2 at 25 °C in a final volume of 50 L. At 5-min intervals (0-15 min), aliquots (4 L) of the pre-incubated enzyme solution were transferred into the assay medium and assayed for residual activity.
For the hNeu2 residual activity assay, the hNeu2 activity was measured in 33 mM MES buffer (pH 6.5) containing 4 mM CaCl 2 and 1 mM 4-MU-NANA at 25 °C. The enzyme reaction was initiated by the addition of the pre-incubated enzyme solution in a final volume of 60 L. The hNeu2 activity was estimated by monitoring the increase in the fluorescence due to the hydrolysis of 4-MU-NANA using an excitation wavelength of 365 nm and an emission wavelength of 450 nm.
